Friday 4 July 2014

South Korea Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

South Korea Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020 is a new market research publication announced by Reportstack. This report provides key market data on the South Korea Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - UFE Procedures using Gelatin Sponge Sheets and UFE Procedures using Polyvinyl Alcohol (PVA) Vials and Tris Acryl Gelatin Microsphere (TAGM) Vials.

The data in the report is derived from dynamic market forecast models. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - UFE Procedures using Gelatin Sponge Sheets and UFE Procedures using Polyvinyl Alcohol (PVA) Vials and Tris Acryl Gelatin Microsphere (TAGM) Vials.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

To view the table of contents and know more details please visit South Korea Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020.

No comments:

Post a Comment